Facilitated By

San Antonio Medical Foundation

mHealth for Patient Self-Management of Opioid Use Disorder

Biomedical Development Corporation

For more than 25 years, Biomedical Development Corporation has been bringing commercially-viable products to market by linking promising technologies with vital sources of research funding.

Principal Investigator(s)
Jennifer Sharpe Potter, Ph.D.
Collaborating Institutions
UT Health San Antonio
Funded by
Research Start Date

This Phase II STTR project furthers the development of KIOS, a digital therapeutic for the treatment of opioid use disorder (OUD). The product to be commercialized is an FDA-approved digital therapeutic (DTx) medical device offered adjunctive to medication assisted therapy (MAT). In contrast to other digital products for OUD, only KIOS offers continuously available, individualized, evidence-based behavioral intervention strategies responsive to a patient's current clinical status outside the context of the doctor’s office or treatment facility.

Collaborative Project
Medical Devices
Behavioral Health